Ovid Therapeutics Inc (OVID) Implied Volatility Current

Tracking OVID implied volatility helps you identify when options premiums on Ovid Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Ovid Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when OVID IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Ovid Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For OVID, tracking metrics like OVID IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on OVID signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule for treating epilepsies. It also develops OV882, a short hairpin RNA gene therapy for the treatment of angelman syndrome; and OV815 for the treatment of kinesin-family of proteins associated neurological disorder.

The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, and Northwestern University, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where OVID implied volatility sits today versus where it has been. Our scanner ranks Ovid Therapeutics Inc implied volatility against its historical range, surfaces extremes in OVID IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Ovid Therapeutics Inc IV is rich or cheap — measure it, then act on it.